TABLE 3-1MDR TB Data from the Russian Federation, 2007–2009

200720082009
Newly detected cases of culture-positive pulmonary TB35,44935,57336,679
Relapse cases of culture-positive pulmonary TB5,8206,2246,159
Newly detected cases investigated for drug susceptibility31,56034,24133,540
Percentage of newly detected cases investigated for drug susceptibility89%91.1%91.4%
Relapse cases investigated for drug susceptibility5,1515,4895,554
Percentage of relapse cases investigated for drug susceptibility88.5%88.2%90.2%
Resistance identified to any drug, newly detected patients10,056
(31.9%)
11,365
(33.2%)
12,116
(36.1%)
Resistance identified to any drug, relapse cases2,307
(44.8%)
2,757
(50.2%)
3,016
(54.3%)
MDR TB identified, newly detected cases4,085
(12.9%)
4,656
(13.6%)
5,193
(15.5%)
MDR TB identified, relapse cases1,280
(24.8%)
1,580
(28.8%)
1,869
(33.7%)

From: 3, Drug-Resistant Tuberculosis in the Russian Federation

Cover of The New Profile of Drug-Resistant Tuberculosis in Russia
The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop.
Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation; Russian Academy of Medical Science.
Washington (DC): National Academies Press (US); 2011.
Copyright © 2011, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.